MTUM vs. ARKG
MTUM (iShares MSCI USA Momentum Factor ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - MTUM is a Momentum fund tracking the MSCI USA Momentum SR Variant Index, while ARKG is a Health & Biotech Equities fund actively managed by ARK. MTUM is passively managed, while ARKG is actively managed. Over the past 10 years, MTUM returned 17.15%/yr vs 7.82%/yr for ARKG. A 0.56 correlation means they provide meaningful diversification when combined. MTUM charges 0.15%/yr vs 0.75%/yr for ARKG.
Performance
MTUM vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MTUM achieves a 29.72% return, which is significantly higher than ARKG's 15.53% return. Over the past 10 years, MTUM has outperformed ARKG with an annualized return of 17.15%, while ARKG has yielded a comparatively lower 7.82% annualized return.
MTUM
- 1D
- 1.69%
- 1M
- 8.76%
- YTD
- 29.72%
- 6M
- 30.51%
- 1Y
- 42.02%
- 3Y*
- 33.16%
- 5Y*
- 14.96%
- 10Y*
- 17.15%
ARKG
- 1D
- -0.53%
- 1M
- 18.90%
- YTD
- 15.53%
- 6M
- 10.83%
- 1Y
- 42.61%
- 3Y*
- -1.68%
- 5Y*
- -17.27%
- 10Y*
- 7.82%
MTUM vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MTUM iShares MSCI USA Momentum Factor ETF | 29.72% | 22.15% | 32.89% | 9.15% | -18.27% | 13.36% | 29.86% | 27.25% | -1.67% | 37.50% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 15.53% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
Correlation
The correlation between MTUM and ARKG is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014 | 0.56 |
The correlation between MTUM and ARKG shifts across timeframes, from 0.43 (1 year) to 0.56 (10 years), reflecting how their relationship changes across market environments.
MTUM vs. ARKG - Sectors Allocation Comparison
Sectors
MTUM
ARKG
Technology
-
Industrials
-
Energy
-
Communication Services
-
Financial Services
Consumer Defensive
-
Healthcare
Consumer Cyclical
-
Basic Materials
-
Real Estate
-
Utilities
-
Technology
MTUM
ARKG
-
Industrials
MTUM
ARKG
-
Energy
MTUM
ARKG
-
Communication Services
MTUM
ARKG
-
Financial Services
MTUM
ARKG
Consumer Defensive
MTUM
ARKG
-
Healthcare
MTUM
ARKG
Consumer Cyclical
MTUM
ARKG
-
Basic Materials
MTUM
ARKG
-
Real Estate
MTUM
ARKG
-
Utilities
MTUM
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MTUM vs. ARKG — Risk / Return Rank
MTUM
ARKG
MTUM vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares MSCI USA Momentum Factor ETF (MTUM) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MTUM | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.97 | ||
| Sortino ratioReturn per unit of downside risk | +1.00 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.18 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 3.55 | 1.52 | +2.03 |
| Martin ratioReturn relative to average drawdown | 13.66 | 3.61 | +10.04 |
Loading charts...
Drawdowns
MTUM vs. ARKG - Drawdown Comparison
The maximum MTUM drawdown since its inception was -34.08%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for MTUM and ARKG.
Loading charts...
Drawdown Indicators
| MTUM | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.08% | -83.59% | +49.51% |
Max Drawdown (1Y)Largest decline over 1 year | -11.54% | -27.51% | +15.97% |
Max Drawdown (3Y)Largest decline over 3 years | -20.99% | -51.96% | +30.97% |
Max Drawdown (5Y)Largest decline over 5 years | -32.28% | -80.18% | +47.90% |
Max Drawdown (10Y)Largest decline over 10 years | -34.08% | -83.59% | +49.51% |
Current DrawdownCurrent decline from peak | -1.55% | -70.05% | +68.50% |
Average DrawdownAverage peak-to-trough decline | -6.20% | -35.95% | +29.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.99% | 11.53% | -8.54% |
Volatility
MTUM vs. ARKG - Volatility Comparison
The current volatility for iShares MSCI USA Momentum Factor ETF (MTUM) is 10.89%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 15.35%. This indicates that MTUM experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MTUM | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.89% | 15.35% | -4.46% |
Volatility (6M)Calculated over the trailing 6-month period | 18.63% | 30.29% | -11.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.87% | 42.16% | -21.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.94% | 45.81% | -24.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.20% | 41.24% | -20.04% |
MTUM vs. ARKG - Expense Ratio Comparison
MTUM has a 0.15% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
MTUM vs. ARKG - Dividend Comparison
MTUM's dividend yield for the trailing twelve months is around 0.61%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
MTUM iShares MSCI USA Momentum Factor ETF | 0.61% | 0.91% | 0.75% | 1.35% | 1.80% | 0.55% | 0.83% | 1.48% | 1.27% | 1.02% | 1.43% | 1.12% |
Frequently Asked Questions
MTUM and ARKG have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (15.35%) compared to MTUM (10.89%). In terms of maximum drawdown, MTUM dropped -34.08% vs ARKG's -83.59%.
On 10-year performance, MTUM leads with 17.15% vs 7.82% for ARKG. On fees, MTUM is cheaper at 0.15% per year. On volatility, MTUM has been the lower-risk option at 10.89%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, MTUM has performed better with a 17.15% return vs 7.82%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
MTUM is cheaper with a 0.15% expense ratio, compared with 0.75% for ARKG.
MTUM has the higher dividend yield at 0.61%, compared with 0.00% for ARKG.
MTUM is categorized as Momentum, while ARKG is Health & Biotech Equities. They also come from different issuers: iShares and ARK. Their fees differ too: 0.15% for MTUM and 0.75% for ARKG.
MTUM currently has the higher Sharpe Ratio (1.96 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MTUM and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer